Searchable abstracts of presentations at key conferences in endocrinology

ea0070oc5.5 | Thyroid | ECE2020

Thyroid dysfunction induced by immune checkpoint inhibitors is associated with a better progression-free-survival and overall survival in non-small cell lung cancer: an original cohort study

Thuillier Philippe , Joly Claire , Roudaut Nathalie , Crouzeix Geneviève , Descourt Renaud , Kerlan Véronique

Objective: Immune checkpoint inhibitors (ICI) are used for treatment of non-small cell lung cancer (NSCLC) and are associated with immune-related adverse events (irAEs), especially thyroid dysfunction. Few studies found an association between thyroid dysfunction and response to Nivolumab in the NSCLC The objective of this retrospective cohort study was to investigate the association between the occurrence of thyroid dysfunction in patients treated with Nivolumab for a NSCLC an...